Clinical Trial Update: EXtended Therapy in Hepatitis C Genotype 3 Infected Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating extended therapy for hepatitis C genotype 3 infection has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: University Health Network, Toronto | Conditions: Chronic Hepatitis C | Phase 3 | Status: TERMINATED